News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Indian hospitals overcharge by design, not complexity
Superhealth CEO argues hospital business models, not medical unpredictability, drive India's high healthcare costs. Pricing for identical procedures varies widely despite low genuine clinical variance.
Healthcare exits favor AI-embedded workflows, not growth stories
Healthcare's exit market is separating well-funded startups from margin-focused companies. Buyers now pay premium prices for AI tools that expand profits, not vanity metrics.
Four factors that determine whether your hospital's AI project will fail
Nordic surveyed healthcare organizations to identify what separates successful AI pilots from failed implementations. The gap usually comes down to data ownership, governance, and workforce readiness.
Healthcare Orgs Need AI Cybersecurity Playbook, Not Just Rules
HSCC released a governance framework for hospitals deploying AI in clinical settings. It covers model drift, data poisoning, and supply chain risks — here's what's inside.
Healthcare AI Needs Operating Models, Not Just Algorithms
HIMSS is hosting AI-focused leadership summits in Boston (June 25-26) and Singapore (August 23-25) to push health systems past pilots into evidence-based deployment. Here's what's actually blocking adoption.
Doctors Save 70 Minutes Daily With AI Scribe, Skip Evening Notes
Beth Israel Lahey Health deployed ambient AI to auto-draft patient visit notes. Clinicians report 74% less after-hours documentation and better eye contact with patients.
Healthcare IT Leaders Meet in Singapore and Boston to Move AI From Talk to Results
HIMSS26 APAC and AI in Healthcare Forum will convene clinicians, technologists, and health system executives in August 2026 and June 2026 to focus on evidence-based AI deployment.
Mayo Clinic and Microsoft build healthcare AI model owned by the clinic
Mayo Clinic will own a new AI model trained on its de-identified clinical data and deployed first within the health system. Microsoft will later offer it via Azure APIs.
NewLimit raises $435M to test first anti-aging drug
Anti-aging biotech NewLimit closed one of 2024's largest venture rounds to advance its lead candidate into human trials. Why the cash surge and what it means for the sector.
House moves to block China biotech deals after Pfizer, Bristol Myers cases
A new bill would add biotechnology to U.S. export controls, following major deals by Pfizer and Bristol Myers that raised national security concerns about China's drugmaking capacity.
Legend's in vivo lymphoma therapy clears all patients in early trial
Legend Biotech's LB2501 showed complete or partial response in 100% of lymphoma patients in initial data. The in vivo approach could compete with Novartis' ex vivo standard Kymriah.
Spanish biotech Ona raises $87M for cancer antibody drugs
Ona Therapeutics, a Barcelona biotech, secured $87 million to develop antibody-drug conjugates targeting advanced breast and colorectal cancers. The funding signals investor confidence in differentiated oncology approaches.